Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03286114
Title Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Michigan Cancer Center
Indications

myelodysplastic syndrome

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Michigan Cancer Center Recruiting Ann Arbor Michigan 48109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field